Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
Condition:   Rectal Cancer Interventions:   Procedure: neoadjuvant chemotherapy plus total mesorectal excision;   Procedure: total mesorectal excision Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials